Molina forecasts fivefold profit growth by 2029, shares fall on cautious outlook

Molina Healthcare told investors it could lift adjusted profit to $20 to $30 a share by 2029, about five times its 2026 outlook, if it can keep medical costs in check. The company also projected premium revenue of about $64 billion in 2029, up from roughly $42 billion expected in 2026, but the market response was wary: shares fell nearly 6% in early trading after the forecast.

The long-range plan rests on a delicate proposition for one of the country’s biggest government-focused insurers. Molina said enrollment in its Medicaid business is expected to fall 2% to 3% a year through 2029, a decline it linked in part to provisions in President Donald Trump’s One Big Beautiful Bill Act. That matters because Medicaid remains Molina’s core business, alongside plans sold through the Affordable Care Act marketplaces. The company’s 2029 pitch was built around the idea that disciplined pricing, state rate updates, contract wins and lower medical-cost pressure can offset slower membership growth and restore margins over time.

Investors, however, appeared to hear a different message. At least two analysts said the outlook landed below market expectations. Barclays said the initial 2029 target was more realistic but still slightly below what investors had hoped for, while J.P. Morgan said the forecast pointed to meaningful earnings power but left open questions about the path to those earnings and how conservative management may be. The reaction underscored how much faith Wall Street is placing in Molina’s ability to manage claims, utilization and reimbursement as medical costs remain volatile across managed care.

That tension between profit ambition and patient care is central to the story. Molina’s first-quarter 2026 Medicaid medical cost ratio was 92.0%, reflecting a rate cycle and medical-cost trend the company described as moderately favorable. But keeping costs “under control” in practice can mean tighter provider networks, more prior authorization, heavier claims review and more scrutiny over utilization, all of which can affect access and speed of care for Medicaid and ACA enrollees.

Molina said it served about 5.5 million members at the end of 2025 across Medicaid, Medicare and Marketplace plans in 21 states, down from about 5.7 million reported in a June 30, 2025 filing. The company had already cut its 2025 profit forecast because of higher medical costs, a warning sign that made the new five-year target look less like a victory lap than a bet that policy, pricing and medical-cost discipline will finally move in the same direction.